"Real World" Administration of Zepatier (Grazoprevir Plus Elvasvir) in Chronic Hemodialysis Patients With Hepatitis C Infection. Strategies for Identification of Patients, Insurance Approval, Treatment , and Laboratory Monitoring
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2018
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 05 Sep 2018 Planned initiation date changed from 15 Jun 2018 to 1 Dec 2018.
- 31 Aug 2018 Biomarkers information updated
- 07 May 2018 Planned initiation date changed from 15 Apr 2018 to 15 Jun 2018.